Analysis of the neu-Encoded Protein and Its Mechanism of Oncogenic Activation
The search for oncogenes and their encoded proteins has involved a variety of experimental procedures and reagents. In our own laboratory, the procedure of gene transfer, also known as transfection, has been used extensively in an attempt to deter oncogenes residing in a variety of tumor DNA’s. These DNA’s have been applied via the Graham-van der Eb calcium phosphate procedure to monolayers of NIH3T3 cells with the hope that some of the transfected cells would respond to donor transforming sequences by demonstrating an altered growth pattern in monolayer. Indeed in this fashion, we and others were able to demonstrate the presence of oncogenes in the DNA’s of a variety of tumor cell types (Varmus 1984).
KeywordsEpidermal Growth Factor Receptor Human Epidermal Growth Factor Receptor NIH3T3 Cell Epidermal Growth Factor Receptor Gene Epidermal Growth Factor Receptor Protein
Unable to display preview. Download preview PDF.
- Bargmann CI, Hung M-C, Weinberg RA (1986a) Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell (submitted)Google Scholar
- Stern DF, Heffernan PA, Weinberg RA (1986) p185, product of the neu proto-oncogene, is a receptor-like protein associated with tyrosine kinase activity. Mol Cell Biol (in press)Google Scholar
- Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (London) 309:418–425CrossRefGoogle Scholar